Lepifre; Franck

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lepifre; Franck.The latest application filed is for "chemical compounds and use thereof for improving muscular quality".

Company Profile

1.22.15

Lepifre; Franck - Saclay FR
LePifre; Franck - Olivet FR
Lepifre; Franck - Longjumeau N/A FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chemical compounds and use thereof for improving muscular quality Grant 10,316,056 - Lafont , et al.	2019-06-11
Chemical Compounds And Use Thereof For Improving Muscular Quality App 20180327444 - LAFONT; RENE ; et al.	2018-11-15
Chemical compounds and use thereof for improving muscular quality Grant 9,938,315 - Lafont , et al. April 10, 2	2018-04-10
Chemical Compounds And Use Thereof For Improving Muscular Quality App 20170226151 - LAFONT; RENE ; et al.	2017-08-10
Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereof Grant 9,365,584 - Cravo , et al. June 14, 2	2016-06-14
Thienopyridone derivatives useful as activators of AMPK Grant 9,284,329 - Cravo , et al. March 15, 2	2016-03-15
Thienopyridone Derivatives Useful As Activators Of Ampk App 20150166566 - Cravo; Daniel ; et al.	2015-06-18
Compounds and method for treatment of cancer Grant 8,822,475 - Danter , et al. September 2, 2	2014-09-02
Quinoxalinedione derivatives useful as activators of AMPK-activated protein kinase Grant 8,674,097 - Cravo , et al. March 18, 2	2014-03-18
Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators Grant 8,604,202 - Cravo , et al. December 10, 2	2013-12-10
Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators Grant 8,563,729 - Cravo , et al. October 22, 2	2013-10-22
Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors Grant 8,486,964 - Valeur , et al. July 16, 2	2013-07-16
Compounds and Method for Treatment of Cancer App 20130165449 - Danter; Wayne R. ; et al.	2013-06-27
Compounds and method for treatment of cancer Grant 8,420,643 - Danter , et al. April 16, 2	2013-04-16
Thieno [2,3-b] Pyridinedione Activators Of Ampk And Therapeutic Uses Thereof App 20130053401 - Cravo; Daniel ; et al.	2013-02-28
Compounds and method for treatment of cancer Grant 8,367,675 - Danter , et al. February 5, 2	2013-02-05
Quinoxalinedione Derivatives App 20120322806 - CRAVO; Daniel ; et al.	2012-12-20
Quinoxalinedione derivatives which are activators of AMPK-activated protein kinase Grant 8,329,698 - Cravo , et al. December 11, 2	2012-12-11
Compounds And Method For Treatment Of Cancer App 20120077820 - Danter; Wayne R. ; et al.	2012-03-29
Compounds And Method For Treatment Of Cancer App 20110281887 - Danter; Wayne R. ; et al.	2011-11-17
Compounds and method for treatment of cancer Grant 8,034,815 - Danter , et al. October 11, 2	2011-10-11
Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors App 20110172265 - Valeur; Eric ; et al.	2011-07-14
Quinoxalinedione Derivatives App 20110130404 - Cravo; Daniel ; et al.	2011-06-02
Thienopyridone Derivatives As Amp- Activated Protein Kinase (ampk) Activators App 20110060001 - Cravo; Daniel ; et al.	2011-03-10
Thienopyridone Derivatives As Amp-activated Protein Kinase (ampk) Activators App 20110034505 - Cravo; Daniel ; et al.	2011-02-10
Compounds And Method For Treatment Of Cancer App 20080171744 - Danter; Wayne R. ; et al.	2008-07-17
Substituted benzo[e][1,4]oxazino[3,2-g]isoindole compounds Grant 7,312,213 - Coudert , et al. December 25, 2	2007-12-25
Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same Grant 7,202,255 - Coudert , et al. April 10, 2	2007-04-10
Substituted benzo[e] [1,4] oxazino [3,2-g] isoindole compounds App 20060003997 - Coudert; Gerard ; et al.	2006-01-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.